AKT1 and renal cell carcinoma: Endogenous molecules, such as fibroblast activation protein‐α (FAP) and cell division cycle‐associated 5 (CDCA5), have been demonstrated to promote the progression of RCC by activating the PI3K/AKT signaling pathway.44, 45